Hee-Seung Bom

Author PubWeight™ 38.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer. Eur J Nucl Med Mol Imaging 2012 2.04
2 Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Eur J Cancer 2011 1.23
3 Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings. Ann Nucl Med 2009 1.19
4 Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol 2007 1.16
5 Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther 2010 1.12
6 Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol 2010 1.11
7 Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica 2004 1.05
8 Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer. Clin Nucl Med 2003 1.04
9 In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 2006 1.03
10 Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. Mol Ther 2013 0.99
11 Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies. J Control Release 2005 0.95
12 Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era. Ann Hematol 2012 0.95
13 Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model. J Nucl Med 2012 0.94
14 Expression of e-cadherin and catenins in early gastric cancer. J Clin Gastroenterol 2002 0.91
15 A stepwise approach using metabolic volume and SUVmax to differentiate malignancy and dysplasia from benign colonic uptakes on 18F-FDG PET/CT. Clin Nucl Med 2012 0.88
16 Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography. Ann Nucl Med 2012 0.87
17 Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation. Cancer Biother Radiopharm 2005 0.86
18 Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT. Clin Nucl Med 2012 0.85
19 Intratumoral injection of 188Re labeled cationic polyethylenimine conjugates: a preliminary report. J Korean Med Sci 2004 0.85
20 Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 2011 0.84
21 Engineering and visualization of bacteria for targeting infarcted myocardium. Mol Ther 2011 0.84
22 Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution. J Nucl Med 2005 0.83
23 Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials 2003 0.83
24 Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer. Lung Cancer 2013 0.82
25 Monitoring the effect of PEGylation on polyethylenimine in vivo using nuclear imaging technique. Nucl Med Biol 2004 0.81
26 Surgically resected isolated hepatic metastasis from non-small cell lung cancer: a case report. J Thorac Oncol 2006 0.80
27 Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival. Anticancer Res 2014 0.79
28 Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice. J Radiat Res 2003 0.79
29 Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole. Stroke 2003 0.79
30 Glucosylated polyethylenimine as a tumor-targeting gene carrier. Arch Pharm Res 2005 0.79
31 Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers. Chonnam Med J 2013 0.78
32 Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: ionic strength-dependent aggregation behavior and (99m)Technetium retention property. Colloids Surf B Biointerfaces 2007 0.78
33 Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol 2013 0.78
34 In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002 0.78
35 The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Ann Hematol 2008 0.78
36 Changes in (18)f-fluorodeoxyglucose uptake in the spinal cord in a healthy population on serial positron emission tomography/computed tomography. Chonnam Med J 2013 0.77
37 Retention of iodine-131 in a thoracic esophageal diverticulum mimicking metastatic thyroid cancer. Clin Nucl Med 2002 0.76
38 Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma. Hell J Nucl Med 2014 0.76
39 Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma. Clin Nucl Med 2003 0.76
40 Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan. Nucl Med Biol 2006 0.76
41 A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment. Case Rep Oncol 2011 0.75
42 A novel method of brachytherapy using local delivery of 99mTc-HMPAO for coronary stent restenosis. Korean J Intern Med 2004 0.75
43 Indirect Radionuclide Coronary Angiography to Evaluate Gradients of Myocardial Blood Flow and Flow Reserve Through Coronary Stenosis Using N-13 Ammonia PET/CT. Chonnam Med J 2013 0.75
44 Characteristics of anginal patients with high resting myocardial blood flow measured with N-13 ammonia PET/CT. Nucl Med Commun 2015 0.75
45 Brain Metastases Mimicking Hyperostosis Frontalis Interna on 99mTc HDP Bone Scintigraphy. Clin Nucl Med 2016 0.75
46 Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study. Nucl Med Commun 2017 0.75
47 Pulmonary tuberculosis mimicking pulmonary metastases on ¹³¹I post-therapeutic scan. Eur J Nucl Med Mol Imaging 2015 0.75
48 Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer. Clin Nucl Med 2016 0.75
49 Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT. Ann Nucl Med 2012 0.75
50 Chitosan oligosaccharide inhibits 203HgCl2-induced genotoxicity in mice: micronuclei occurrence and chromosomal aberration. Arch Pharm Res 2005 0.75
51 Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer. Clin Nucl Med 2012 0.75
52 Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET. Clin Nucl Med 2008 0.75
53 Diffuse soft tissue uptake of I-131 after post-thyroidectomy ablation therapy for thyroid cancer. Clin Nucl Med 2002 0.75
54 Quantitative Evaluation of incomplete embolization in a patient with portosystemic shunt by per-rectal portal scintigraphy. Clin Nucl Med 2012 0.75